Sitting on a Cash Pile 12.0? BioTech Favored Over Legacy Pharma
#cash #bullish #buy
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) brokout on 10 November at 4.08 and confirmed on 11 March at 11.98. Thus garnering an LTN Cash Pile Buy rating with a 1yr price target at 16+/share
The stock is currently trading at 11.98 within its 52 wk trading range of 1.58 - 12.90
The consensus 1 yr price objective is 13.78. Our price target is 16/share.
The Key support is at 11.17 and the resistance is light at 12.72. the majority of our Key technical indicators are Very Bullish in here.
BioCryst Pharmaceuticals, Inc., a biotech company, discovers oral and small-molecule medicines.
The company markets peramivir injection, an intravenous neuraminidase inhibitor, for the treatment of acute uncomplicated influenza under the RAPIVAB, ALPIVAB, RAPIACTA, and PERAMIFLU names; and Mundesine, an oral purine nucleoside phosphorylase inhibitor for peripheral T-cell lymphoma.
It is also developing BCX7353, an oral serine protease inhibitor and oral dose formulation that is in Phase III clinical trials to treat hereditary angioedema; BCX9930, an oral factor D inhibitor, which is in Phase I clinical trials for mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitors that is in Phase I clinical trials to treat fibrodysplasia ossificans progressiva; and Galidesivir, a RNA dependent-RNA polymerase inhibitor, which is in Phase I clinical trials to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika.
The company has collaborations and in-license relationships with US Department of Health and Human Services; National Institute of Allergy and Infectious Diseases; Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; Mundipharma International Holdings Limited; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd.
BioCryst Pharmaceuticals, Inc. was founded in Y 1986 and is HQ'd in Durham, North Carolina.
Have a healthy day, Keep the Faith!
Larry Fink Called It. CME Just Made It Real. The Compute Futures Market Has Arrived
The Quantum-AI Convergence Is Real. The Quantum Stocks Aren't the Trade.
The future is now 5 emerging technologies to watch comfort begins
Timely updates and reliable reporting on politics, global events, science, and culture. Our concise news summaries help you understand complex issues quickly and accurately, keeping you always informed.
Popular streaming service announces new subscription worldwide
Your trusted news source bringing you fast, factual updates from around the globe politics economy science reports.
Every story, signed and delivered.
Subscribe to the kxco channel and get the headline, the AI-written key takeaways, and the chain-anchor link the moment we publish. Audio versions and per-ticker subscriptions arrive in the next iteration.